Table 1.
Step | Parameter | Value | Description |
---|---|---|---|
1 | Cells | 30 μL | 30,000 cells/well, overnight |
2 | Wash | 25 μL × 3 | Pipetting and aspiration |
3 | Buffer #2 | 30 μL | 1% DMSO with assay buffer |
4 | Incubation time | 2 h | Equilibrate in EnSpire (25°C) |
5 | Baseline reading | 4 min | Keep temperature constant |
6 | Compound | 10 μL | Compounds in 1% DMSO with assay buffer |
7 | Final reading #1 | 30 min | EnSpire (25°C) |
8 | UII | 10 μL | Urotensin II in assay buffer |
9 | Final reading #2 | 30 min | EnSpire (25°C) |
10 | Analysis |
Step Notes
1. Performed in EnSpire-LFC, 384-well fibronectin-coated plates. Day 1: cell seeding (UT receptor transfected-HEK293, 30,000 cells/well), 37°C incubator overnight.
2. Day 2: washing with buffer #2 (1 × HBSS, 20 mM HEPES, 1% DMSO), 25 μL × 3 remove all with aspiration.
3. Add 30 μL of buffer #2.
4. Equilibrate for 2 h in EnSpire (keep temperature constant). While cell plate is equilibrating, prepare compound dilution plates.
5. Baseline measurement.
6. Add 10 μL of compounds (×4). Columns 1–3, buffer #2; columns 4–12, various concentrations of compounds.
7. Quickly reload plate into EnSpire for final read #1(∼30 min).
8. Add 10 μL of urotensin II (×5).
9. Quickly reload plate into EnSpire for final read #2(∼30 min).
10. Analysis respective EC50 or IC50 values.